NIDAVANH KLOPFENSTEIN: Open Payments
NPI 1275694911 · COLUMBUS, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$534 in 17 payments from 7 companies in 2025. Trend: 2023 $805 · 2024 $441 · 2025 $534
Food & beverage: $534
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 4 | $157 |
| E.R. Squibb & Sons, L.L.C. | 4 | $152 |
| Alkermes, Inc. | 3 | $88 |
| Janssen Pharmaceuticals, Inc | 3 | $69 |
| Axsome Therapeutics, Inc. | 1 | $25 |
| Corium, LLC | 1 | $22 |
| Noven Therapeutics, LLC | 1 | $21 |
Products named: VRAYLAR, COBENFY, INVEGA SUSTENNA, ARISTADA, LYBALVI, Auvelity, Azstarys, Secuado.
Industry payments across IN — which companies pay providers there.
